McKesson | Occupy World Writes

Three pharmaceutical companies distributed 81 million opioid painkillers in a West Virginia county over an eight-year period, but the federal judge ruled they were not liable for the damage done by the opioid epidemic.

By Julia Conley Published 7-5-2022 by Common Dreams

A federal judge ruled on July 4, 2022 that three pharmaceutical companies are not liable for the damage that their sales of opioids did to a community in West Virginia. (Photo: VCU CNS/Flickr/cc)

A community in West Virginia is planning to appeal a ruling handed down Monday by a federal judge who concluded that three pharmaceutical companies are not liable for the vast damage done to the area by their shipments of millions of opioids.

Cabell County and the city of Huntington argued in court last year that AmerisourceBergen, Cardinal Health, and McKesson had created a “public nuisance” by distributing more than 81 million hydrocodone and oxycodone pills in the area over an eight-year period, saying the companies made no effort to ensure the pills were fulfilling legitimate prescriptions and wouldn’t be sold on the black market. Continue reading →

by Robert Faturechi ProPublica, June 1, 2017, 8 a.m.

Tom Price. Photo: Gage Skidmore [CC BY-SA 2.0], via Wikimedia Commons

In the spring before the 2016 presidential election, the Obama administration’s 12-nation trade agreement known as the Trans-Pacific Partnership, or TPP, was still alive. Negotiators worked on details as Congress considered whether to ratify the pact.

The Australian government was getting in the way of one change demanded by U.S. pharmaceutical companies. Makers of cutting-edge biological drugs wanted to have data from their clinical trials protected from competitors for 12 years, as they are under U.S. law 2014 not the roughly five years permitted under the TPP. Australian officials insisted that an extension would deprive consumers of cheaper alternatives for too long. Continue reading →

Occupy World Writes

The Movement Continues – Globally

Tag Archives: McKesson

Tom Price Bought Drug Stocks. Then He Pushed Pharma’s Agenda in Australia